
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nobiletin as an inducer of programmed cell death in cancer: a review
Jun Huang, Zaoshang Chang, Quzhe Lu, et al.
APOPTOSIS (2022) Vol. 27, Iss. 5-6, pp. 297-310
Closed Access | Times Cited: 44
Jun Huang, Zaoshang Chang, Quzhe Lu, et al.
APOPTOSIS (2022) Vol. 27, Iss. 5-6, pp. 297-310
Closed Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
The interactions of docetaxel with tumor microenvironment
Reena Gupta, Mustafa M. Kadhim, Abduladheem Turki Jalil, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110214-110214
Closed Access | Times Cited: 44
Reena Gupta, Mustafa M. Kadhim, Abduladheem Turki Jalil, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110214-110214
Closed Access | Times Cited: 44
Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer
Chunmei Zhang, Ning Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
Chunmei Zhang, Ning Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products
Holya A. Lafta, Ali Hamid AbdulHussein, Saif A. J. Al-Shalah, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 12, pp. 1104-1122
Closed Access | Times Cited: 39
Holya A. Lafta, Ali Hamid AbdulHussein, Saif A. J. Al-Shalah, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 12, pp. 1104-1122
Closed Access | Times Cited: 39
Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer
Maria Beatriz Madureira, Virgínia Márcia Concato, Ellen Mayara Souza Cruz, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 586-586
Open Access | Times Cited: 35
Maria Beatriz Madureira, Virgínia Márcia Concato, Ellen Mayara Souza Cruz, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 586-586
Open Access | Times Cited: 35
Tumor microenvironment remodeling in oral cancer: Application of plant derived-natural products and nanomaterials
Hendrik Setia Budi, Bagher Farhood
Environmental Research (2023) Vol. 233, pp. 116432-116432
Closed Access | Times Cited: 25
Hendrik Setia Budi, Bagher Farhood
Environmental Research (2023) Vol. 233, pp. 116432-116432
Closed Access | Times Cited: 25
Deep Eutectic System-Based Liquisolid Nanoparticles as Drug Delivery System of Curcumin for In-Vitro Colon Cancer Cells
Abdeh Nakaweh, Faisal Al-Akayleh, Mayyas Al‐Remawi, et al.
Journal of Pharmaceutical Innovation (2024) Vol. 19, Iss. 2
Closed Access | Times Cited: 11
Abdeh Nakaweh, Faisal Al-Akayleh, Mayyas Al‐Remawi, et al.
Journal of Pharmaceutical Innovation (2024) Vol. 19, Iss. 2
Closed Access | Times Cited: 11
Modulation of the immune system by melatonin; implications for cancer therapy
Masoud Moslehi, Reza Moazamiyanfar, Mohammad Sedigh Dakkali, et al.
International Immunopharmacology (2022) Vol. 108, pp. 108890-108890
Closed Access | Times Cited: 38
Masoud Moslehi, Reza Moazamiyanfar, Mohammad Sedigh Dakkali, et al.
International Immunopharmacology (2022) Vol. 108, pp. 108890-108890
Closed Access | Times Cited: 38
Mechanisms of cancer cell killing by metformin: a review on different cell death pathways
Xiaoyu Wu, Wenwen Xu, Xiangkun Huan, et al.
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 1, pp. 197-214
Closed Access | Times Cited: 32
Xiaoyu Wu, Wenwen Xu, Xiangkun Huan, et al.
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 1, pp. 197-214
Closed Access | Times Cited: 32
Nobiletin in Cancer Therapy; Mechanisms and Therapy Perspectives
Reza Moazamiyanfar, Sepideh Rezaei, Hasan Aliashrafzadeh, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 22, pp. 1713-1728
Closed Access | Times Cited: 22
Reza Moazamiyanfar, Sepideh Rezaei, Hasan Aliashrafzadeh, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 22, pp. 1713-1728
Closed Access | Times Cited: 22
Recent advances in the therapeutic potential of nobiletin against respiratory diseases
Yanqin Qin, Jingfan Yang, Haibo Li, et al.
Phytomedicine (2024) Vol. 128, pp. 155506-155506
Open Access | Times Cited: 7
Yanqin Qin, Jingfan Yang, Haibo Li, et al.
Phytomedicine (2024) Vol. 128, pp. 155506-155506
Open Access | Times Cited: 7
Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway
Heng Wang, Qin-Qin Tian, Ruijing Zhang, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Heng Wang, Qin-Qin Tian, Ruijing Zhang, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Nrf2-mediated therapeutic effects of dietary flavones in different diseases
Wenkai Huang, Yuan Zhong, Botao Gao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 16
Wenkai Huang, Yuan Zhong, Botao Gao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 16
Mechanisms of Cancer-killing by Quercetin; A Review on Cell Death Mechanisms
Hehua Wang, Ziyu Dong, Jinhai Liu, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 9, pp. 999-1012
Closed Access | Times Cited: 15
Hehua Wang, Ziyu Dong, Jinhai Liu, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 9, pp. 999-1012
Closed Access | Times Cited: 15
Mechanisms of cancer cell death induction by triptolide
Ali Hamid AbdulHussein, Muataz Mohammed Al‐Taee, Zahra Abdul Radih, et al.
BioFactors (2023) Vol. 49, Iss. 4, pp. 718-735
Closed Access | Times Cited: 13
Ali Hamid AbdulHussein, Muataz Mohammed Al‐Taee, Zahra Abdul Radih, et al.
BioFactors (2023) Vol. 49, Iss. 4, pp. 718-735
Closed Access | Times Cited: 13
A new insight into Cd exposure-induced hemocyte reduction in Lymantria dispar larvae: Involvement of the ROS-ATF6-ER stress-apoptosis pathway
Fusen Yue, Jinsheng Xu, Lin-Yi Meng, et al.
Journal of Hazardous Materials (2024) Vol. 469, pp. 134061-134061
Closed Access | Times Cited: 5
Fusen Yue, Jinsheng Xu, Lin-Yi Meng, et al.
Journal of Hazardous Materials (2024) Vol. 469, pp. 134061-134061
Closed Access | Times Cited: 5
An exploratory study on the molecular targets and interaction mechanisms of citri reticulatae pericarpium (CRP) in the treatment of chronic obstructive pulmonary disease (COPD) based on GEO combined with bioinformatics
Jia Jia, Enming Cui, Si Li, et al.
CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (CHINESE VERSION) (2025), pp. 100516-100516
Open Access
Jia Jia, Enming Cui, Si Li, et al.
CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (CHINESE VERSION) (2025), pp. 100516-100516
Open Access
Unveiling Novel Targets in Lung Tumors for Enhanced Radiotherapy Efficacy: A Comprehensive Review
Faris Anad Muhammad, Ayat Hussein Adhab, Morug Salih Mahdi, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access
Faris Anad Muhammad, Ayat Hussein Adhab, Morug Salih Mahdi, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access
Doxorubicin-Induced Cardiac Remodeling: Mechanisms and Mitigation Strategies
Yingpu Sun, Lili Xiao, Linlin Chen, et al.
Cardiovascular Drugs and Therapy (2025)
Closed Access
Yingpu Sun, Lili Xiao, Linlin Chen, et al.
Cardiovascular Drugs and Therapy (2025)
Closed Access
Phytochemicals and their Nanoformulations for Overcoming Drug Resistance in Head and Neck Squamous Cell Carcinoma
Zhai Pingping, Nan Chen, Yong Tang
Pharmaceutical Research (2025)
Closed Access
Zhai Pingping, Nan Chen, Yong Tang
Pharmaceutical Research (2025)
Closed Access
Redefining Hepatocellular Carcinoma Treatment: Nanotechnology Meets Tumor Immune Microenvironment
Chen Mi, Sai Liu, Zhida Chen
Journal of drug targeting (2025), pp. 1-47
Closed Access
Chen Mi, Sai Liu, Zhida Chen
Journal of drug targeting (2025), pp. 1-47
Closed Access
Protection against cancer therapy-induced cardiovascular injury by planed-derived polyphenols and nanomaterials
Yunshu Liao, Qinghua Meng
Environmental Research (2023) Vol. 238, pp. 116896-116896
Closed Access | Times Cited: 10
Yunshu Liao, Qinghua Meng
Environmental Research (2023) Vol. 238, pp. 116896-116896
Closed Access | Times Cited: 10
Targeting the breast tumor microenvironment by plant-derived products and their nanoformulations
Hongpeng Zhang, Yanshu Li
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105432-105432
Closed Access | Times Cited: 3
Hongpeng Zhang, Yanshu Li
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105432-105432
Closed Access | Times Cited: 3
Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticles
Chou‐Yi Hsu, Mohammed Ahmed Mustafa, Ashwani Kumar, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155266-155266
Closed Access | Times Cited: 3
Chou‐Yi Hsu, Mohammed Ahmed Mustafa, Ashwani Kumar, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155266-155266
Closed Access | Times Cited: 3
Phytochemicals and Their Nanoformulations for Targeting Hepatocellular Carcinoma: Exploring Potential and Targeting Strategies
Safia Obaidur Rab, R Roopashree, Farag M. A. Altalbawy, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 8
Open Access | Times Cited: 3
Safia Obaidur Rab, R Roopashree, Farag M. A. Altalbawy, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 8
Open Access | Times Cited: 3
Boosting Anti-tumour Immunity Using Adjuvant Apigenin
Chuli Xiao, Masoud Najafi, Jun Huang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 3, pp. 266-277
Closed Access | Times Cited: 15
Chuli Xiao, Masoud Najafi, Jun Huang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 3, pp. 266-277
Closed Access | Times Cited: 15